期刊文献+

替米沙坦对糖尿病大鼠肾脏表达E-选择素的影响 被引量:5

下载PDF
导出
摘要 目的探讨替米沙坦对E-选择素(E-selectin)表达的影响和对糖尿病肾病(DN)的保护作用。方法左肾切除后单次腹腔注射50 mg/kg链脲佐菌素制备糖尿病(DM)大鼠模型,随机分成DM组、替米沙坦组(5 mg.kg-1.d-1)和正常对照组。用免疫组化及Western印迹的方法检测12 w后大鼠肾脏E-selectin表达的改变。结果与正常对照组相比,DM组及替米沙坦组E-selectin表达明显增加(P<0.01);而替米沙坦组E-selectin表达显著低于DM组(P<0.01)。结论替米沙坦可抑制DM大鼠肾脏E-selectin的表达,延缓DN发生、发展。
作者 马旭 邵凤明
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第6期1344-1346,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献15

  • 1王奕丽,刘国良.2型糖尿病患者早期肾脏改变与血清可溶性E-选择素的相关关系[J].中国糖尿病杂志,2003,11(5):373-374. 被引量:1
  • 2邢玉波,李红.粘附分子与糖尿病[J].国外医学(内分泌学分册),2001,21(1):6-8. 被引量:13
  • 3郭志勇,崔若兰.细胞间粘附分子-1在肾小球炎症过程中的作用及氯沙坦对其影响[J].第二军医大学学报,2000,21(1):42-44. 被引量:10
  • 4Sviglerova J,Kuncova J,Tonar Z.Streptozotocirrindudced model of type 1 diabetes mellitus[J].Cesk Fysiol,2006;55(3):96-102.
  • 5Hirata K,Shikata K,Matsuda M,et al.Increased expression of selectins in kidneys of patients with diabetic nephropathy[J].Diabetologia,1998;41(2):185-92.
  • 6Narumi S,Onozato ML,Tojo A,et al.Tissue-specific induction of E-selec-tin in glomeruli is augmented following diabetes mellitus[J].Nephron,2001;89(2):161-71.
  • 7Tailor A,Granger DN.Role of adhesion molecules in vascular regulation and damage[J].Curr Hypertens Rep,2000;2(1):78-83.
  • 8Shestakova MV,Kochemasova TV,Gorelysheva VA,et al.The role of ad-hesion molecules(ICAM-1 and E-selectin)in development of diabetic microangiopathies[J].Ter Arkh,2002;74(6):24-7.
  • 9Blaha V,Andrs C,Smahelova A,et al.Effect of atorvastatin on soluble CD14,CD40 ligand,sE-and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus:relationship to cholesterol turnover[J].Pharmacol Res,2006;54(6):421.
  • 10Hirata F,Yoshida M,Ogura Y.High glucose exacerbates neutrophil to human retinal endothelial cells[J].Exp Eye Res,2006;82(1):179.

二级参考文献38

共引文献124

同被引文献47

  • 1LI M,PASCUAL G, GLASS C K. Peroxisome proliferator-activated receptor garrima-dependenl repression of theindudble nitric oxide synthase gene [ J ]. Mol Cell Biol,2000,20(13) :4699-4707.
  • 2LAKSHMANAN A P,WATANABE K,THANDAVARAYANR A,et al. Telmisartan attenuates oxidative stress and renalfibrosis in streptozotocin induced diabetic mice with thealteration of angiotensin-( 1-7) mas receptor expressionassociated with its PPAR-gamma agonist action [ J ]. FreeRadic Res,2011 ,45(5) :575-584.
  • 3OTT I M,ALTER M L,VON WEBSKY K,et al. Effects ofstimulation of soluble guanylate cyclase on diabeticnephropathy in diabetic eNOS knockout mice on top ofangiotensin II receptor blockade [ J ]. PLoS One, 2012, 7(8):e42623.
  • 4LEE W C, CHEN H C, WANG C Y, et al. Cilostazolameliorates nephropathy in type 1 diabetic rats involvingimprovement in oxidative stress and regulation of TGF-Betaand NF-kappaB [ J ]. Biosci Biotechnol Biochem, 2010, 74(7):1355-1361.
  • 5CAO Z,COOPER M E. Efficacy of renin-angiotensin system(RAS) blockers on cardiovascular and renal outcomes inpatients with type 2 diabetes [ J ]. Acta Diabetol, 2012,49(4):243-254.
  • 6SHARMA A M,STAELS B. Review:Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipidand glucose metabolism[ J] . J Clin Endocrinol Metab,2007,92(2) :386-395.
  • 7DI GREGORIO G B, YAO-BORENGASSER A,RASOULIN,et al. Expression of CD68 and macrophage chemoat-txactant protein-1 genes in human adipose and muscletissues: association with cytokine expression,insulinresistance,and reduction by pioglitazone [ J ]. Diabetes,2005,54(8) :2305-2313.
  • 8WEISBERG S P, MCCANN D,DESAI M,et al. Obesity isassociated with macrophage accumulation in adipose tissue[J]. J Clin Invest,2003,112(12) : 1796-1808.
  • 9BROEDERS N, ABRAMOWICZ D. Peroxisome proliferator-activated receptors ( PPARs ) : novel therapeutic targets inrenal disease[ J]. Kidney Int ,2002,61 ( 1) :354-355.
  • 10YANG H C,DELEUZE S,ZUO Y,et al. The PPARgammaagonist pioglitazone ameliorates aging-related progressiverenal injury [ J ] . J Am Soc Nephrol,2009,20 ( 11) : 2380 -2388.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部